Corrigendum to “Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer” [Gynecologic Oncology, Volume 165, Issue 2, May 2022, Pages 270–280] (Gynecologic Oncology (2022) 165(2) (270–280), (S0090825822001767), (10.1016/j.ygyno.2022.03.005))

Jung In Shim, Ji Yoon Ryu, Soo Young Jeong, Young Jae Cho, Jung Joo Choi, Jae Ryoung Hwang, Ju Yeon Choi, Jason K. Sa, Jeong Won Lee

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors regret that Figure 6 was published truncated and data C was missing. Full Figure 6 can be found below. The authors would like to apologise for any inconvenience caused.[Formula

Original languageEnglish
Pages (from-to)370-371
Number of pages2
JournalGynecologic Oncology
Volume166
Issue number2
DOIs
Publication statusPublished - 2022 Aug

Bibliographical note

Publisher Copyright:
© 2022 Elsevier Inc.

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynaecology

Fingerprint

Dive into the research topics of 'Corrigendum to “Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer” [Gynecologic Oncology, Volume 165, Issue 2, May 2022, Pages 270–280] (Gynecologic Oncology (2022) 165(2) (270–280), (S0090825822001767), (10.1016/j.ygyno.2022.03.005))'. Together they form a unique fingerprint.

Cite this